Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.31 | 6e-21 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-11 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.34 | 1e-10 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-07 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.3 | 4e-07 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 4e-06 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 2e-05 |